AmerisourceBergen to Sell Provectus Pharmaceuticals' Pure-ific Antibacterial Hand Spray

Article

KNOXVILLE, Tenn. Provectus Pharmaceuticals, Inc. announced today that AmerisourceBergen will sell the company's first over-the-counter (OTC) product, Pure-ific Antibacterial Hand Spray. AmerisourceBergen is a leading distributor of pharmaceutical products and services to independent and chain pharmacies, as well as the hospital market, physician's offices, alternate care and mail-order facilities.

   

Pure-ific, which comes in a 1-ounce can, is designed to immediately kill up to 99.9 percent of germs on skin and prevents re-growth for up to six hours. It is packaged as a quick-drying spray, leaves no sticky residue, and is appropriate both for hands and for hard surfaces, such as toilet seats.

   

AmerisourceBergen services the Good Neighbor Pharmacy Network and the Family Pharmacy Network.  "Through our relationship with AmerisourceBergen, we

hope to grow sales throughout the 2,000-member Good Neighbor Pharmacy Network,

and then expand into the 2,500-store Family Pharmacy Network, as well," said

Timothy C. Scott, PhD, Provectus president.

   

Scott said the AmerisourceBergen agreement is significant to Provectus for

two reasons.  "First, this agreement will launch our Pure-ific sales

program into the private pharmacies market," Scott said.  "Second, the

revenues generated through Pure-ific sales will minimize our need for

additional external funding to support our core work -- clinical trials in

oncology and dermatology.  That has always been a vital part of our corporate

strategic plan to maximize shareholder value."

 

Source: Provectus Pharmaceuticals, Inc.

 

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.